Approval for process validation of the proposed device sterilization procedure, proposed labeling for the device packaging, and the proposed changes to the instruction manual.  The device, as modified, will be marketed under the trade name mark iv and is indicated for persons who require chronic ventilatory support because oof upper motor neuron respiratory muscle paralysis (rmp) or because of central alveolar hypoventilation (cah) and whose remaining phrenic nerve, lung, and diaphragm function